Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > No reverse split

<< Previous

Bullboard Posts

Next >>

Comment by hmmmmmmmmon May 24, 2024 12:30pm

164 Views

Post# 36056094

RE:RE:RE:No reverse split

THIS is the find. Huge. As some of us discussed here back in Jan/ Feb - the word was 2 BOD seats would change and one would go to Baxter... (Walker and Franzi)

Baxter is really working hard to keep their involvment on the DL... Not looking at interim (not allowing the market to see interim), making the smallest 2M milestone payment, not taking the open seat on the BOD...

But now that quietly being reversed- the board seat is now controlled and I'll bet Baxter is part of financing that it about to close...

Question is who are they hiding their PMX interest from? PE? ?

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles